---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-237998"
form_type: "8-K"
ticker: "LRMR"
cik: "0001374690"
company_name: "Larimar Therapeutics, Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:51:55.206292+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Larimar posts updated corporate presentation; no financial or clinical data in filing

## Summary
- The 8-K filed on Oct 14, 2025, indicates an updated slide deck was posted on the company website.
- No numerical data, pipeline updates, or financial guidance were included in the filing text.
- The slide presentation (Exhibit 99.1) is referenced but its content is not available for review.
- Investors are directed to the company website for the full presentation.

## SEC filing metadata
- accession: 0001193125-25-237998
- form_type: 8-K
- ticker: LRMR
- cik: 0001374690
- company_name: Larimar Therapeutics, Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374690/000119312525237998/0001193125-25-237998-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374690/000119312525237998/lrmr-20251014.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-237998
- JSON: https://secwatch.observer/filing/0001193125-25-237998.json
- Plain text: https://secwatch.observer/filing/0001193125-25-237998.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.